VIDEO: Israel Approves MDMA Trial for PTSD Sufferers
The approval of an MDMA drug trial for individuals suffering from post-traumatic stress disorder (PTSD) offers hope for a potential medical breakthrough in treating this debilitating condition.
Israel has taken a significant step forward in addressing the mental health challenges faced by its citizens, particularly those affected by the lasting trauma of war, terror attacks, and rockets.
The approval of an MDMA drug trial for individuals suffering from post-traumatic stress disorder (PTSD) offers hope for a potential medical breakthrough in treating this debilitating condition.
Professor Nadav Davidovitch, the chair of the Israeli Public Health Physicians Association, plays a pivotal role in dissecting the implications and potential benefits of this innovative approach to help alleviate the suffering of many Israelis and people around the world afflicted by PTSD.
(adsbygoogle = window.adsbygoogle || []).push({});
(adsbygoogle = window.adsbygoogle || []).push({});
(adsbygoogle = window.adsbygoogle || []).push({});
(adsbygoogle = window.adsbygoogle || []).push({});
Do You Love Israel? Make a Donation to Show Your Support!
Donate to vital charities that protect Israelis and help inspire millions around the world to support Israel too!
Now more than ever, Israel needs your help to fight – and win – the battle of public opinion.
Anti-Israel bias and boycotts are out of control. Israel’s enemies effectively use social media to incite brutal terror against innocent Israeli civilians. Please help us fight back!
The post WATCH: Israel Approves MDMA Trial for PTSD Sufferers first appeared on United with Israel.
United with Israel
